Fundraising Fox

Ankyra Therapeutics

Austin, US · Founded 2019 · Delaware corporation · 25 employees on LinkedIn · 7 known investors

Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.

BiotechDeep TechHealthtechMedical Devices

Founders & leadership

Ankyra Therapeutics was founded in 2019 by Tillman Gerngross.

TG
Tillman GerngrossFounder

Board

TM
Terrance McGuireBoard director

Investors · 7

GV (Google Ventures)Mountain View · $250K – $50M
Fidelity InvestmentsreportedBoston
Mithril Capital Managementreported · 2 sourcesAustinvia Ajay Royan · board
Polaris PartnersreportedBoston · $500K – $5M
Sands Capital VenturesreportedArlington · $10M – $30M
Spring Mountain CapitalreportedNew York

Also in the syndicate · 1

Borealis Ventures

Funding

SEC filings, press & company announcements

$59.5M disclosed across 2 of 3 rounds · 2020–2024

▶$45MraisedSep 2021 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ajay RoyanDirector
  • Terrance McGuireDirector
  • Tillman GerngrossExecutive Officer, Director
  • Philip FerneauDirector
Offering amount
$45M
Amount sold
$45M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.5MraisedMay 2020 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Terrance McGuireDirector
  • Tillman GerngrossExecutive Officer, Director
Offering amount
$14.5M
Amount sold
$14.5M
First sale
May 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Bioworld31 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Ankyra Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Ankyra Therapeutics announces $45 Million Series B Financing and Appoints Howard L. Kaufman M.D. as Chief Medical Officer - Ankyraankyratx.com · Oct 2024Ankyra Therapeutics - Medtech Alertmedtechalert.com · Dec 2022Ankyra Therapeutics, Inc Says Has Raised $14.5 Million In Equity Financing | Reutersreuters.com · May 2020

Frequently asked questions

What does Ankyra Therapeutics do?
Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.
Who founded Ankyra Therapeutics?
Ankyra Therapeutics was founded by Tillman Gerngross in 2019.
Who are Ankyra Therapeutics's investors?
Ankyra Therapeutics's investors include GV (Google Ventures), Fidelity Investments, Mithril Capital Management, Polaris Partners, Sands Capital Ventures, Spring Mountain Capital.
How much funding has Ankyra Therapeutics raised?
Ankyra Therapeutics has disclosed $59.5M raised across 2 of its 3 known rounds.
Where is Ankyra Therapeutics headquartered?
Ankyra Therapeutics is headquartered in Austin, US.